CONDUCT PROTEIN ANALYSIS SERVICES IN SUPPORT OF CANCER RESEARCH
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of Veterans Affairs is soliciting protein analysis services to support cancer research focused on optimizing treatment for Veterans with metastatic prostate cancer. The project involves a longitudinal study conducted by the Washington DC VA Medical Center targeting Veterans diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). Participants will provide serial peripheral blood samples at specific intervals before, during, and after treatment to enable detailed proteomic analysis. This contract, solicited under the number 36C24526Q0565, was posted on June 11, 2026, with a response deadline of June 26, 2026. The services are to be performed primarily in Washington, D.C., and fall under the NAICS code 541715, which pertains to research and development in the physical, engineering, and life sciences. The solicitation is open with no set-aside restrictions, and the office responsible for the contract is located in Linthicum, Maryland. Interested parties can contact Veronica B. Dillard for more information regarding this combined type contract aimed at advancing cancer treatment through AI-guided blood proteomics.
General Info
Agency
NAICS
Place of Performance
Washington, DC, 20422, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
AI-Guided Blood Proteomics for Treatment Optimization in Veterans with Metastatic Prostate Cancer.The Washington DC VA Medical Center (DC VAMC) is conducting a longitudinal study enrolling Veterans with metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). Serial peripheral blood specimens are collected at predefined timepoints before, during, and after treatment.
